Exposure is the key to grow under the shadow of Dendreon.
Quite a unique situation which has never before been seen with an Australian listed biotech and for this reason I remain of very firm belief over the next 12-24 months we will see some very surprising sp increases.
Dendreon is only now starting to get huge positive exposure for their provenge treatment and new calls for $100 are very valid since the medicare decision imo. Analysts are now predicting they will be over $55 before June.
On a comparative scale a $100 Dendreon share would be equivilent to a Prima share being worth $15.98
I would accept these figures sound ridiculous to some but then I'm sure exactly 2 years ago $2.60 Dendreon holders would've thought the same thing.
Immunotherapy treatment is a huge break through and holds a lot of hope for many cancer sufferers around the world, not just those suffering from Prostate or Ovarian cancer.
- Forums
- ASX - By Stock
- IMM
- ok - prima is one of the best on asx
ok - prima is one of the best on asx, page-5
-
- There are more pages in this discussion • 41 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
(20min delay)
|
|||||
Last
34.0¢ |
Change
-0.015(4.23%) |
Mkt cap ! $493.8M |
Open | High | Low | Value | Volume |
35.0¢ | 35.8¢ | 33.5¢ | $1.374M | 3.957M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 95461 | 34.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
34.5¢ | 48512 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 95461 | 0.340 |
3 | 125869 | 0.335 |
9 | 168422 | 0.330 |
5 | 187373 | 0.325 |
10 | 175181 | 0.320 |
Price($) | Vol. | No. |
---|---|---|
0.345 | 48512 | 1 |
0.350 | 78512 | 2 |
0.355 | 81512 | 3 |
0.360 | 162674 | 4 |
0.365 | 56000 | 3 |
Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |